abrdn Announces Its Appointment to Four U.S. Specialist Healthcare Closed-End Funds, New Board of Trustees to the Funds and Fund Name Changes

Stock Information for abrdn Life Sciences Investors Shares of Beneficial Interest

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About abrdn Life Sciences Investors Shares of Beneficial Interest

abrdn U.S. Closed-End Funds Announce Distribution Payment Details
abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update
abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in Distribution Rate
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
Tekla Capital Management LLC Announces Closing of Transaction With abrdn
Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc.
Tekla Funds Implore Shareholders of THQ and THW to Vote Immediately to Realize Potential Cost Savings for the Funds
Tekla Funds Urge Shareholders to Vote Immediately to Guarantee Reduced Fund Expenses

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.